Browse the evidence

For people with BMI 30–40 kg/m2 or abdominal obesity and complications, a weight loss target of 10–15% body weight is recommended.

Practitioners should target a 10-15% weight loss for this patient group.

A weight loss target of > 15% is recommended for those with BMI > 40 kg/m2 and complications.

Practitioners should aim for more than 15% weight loss in this patient group and consider referral to specialists.

If all eligible individuals received medically tailored meals (MTMs), an estimated 1,594,000 hospitalizations could potentially be averted in 1 year.

Healthcare providers should consider the potential benefits of MTMs in reducing hospitalizations for eligible patients.

Current therapy interventions for NAFLD are mainly focused on progressive weight loss through modulation of overall calorie intake with or without specific macronutrient adjustments.

Practitioners should focus on calorie intake modulation for weight loss in NAFLD management.

Liquid meal replacements in weight loss diets lead to a mean reduction in body weight of −2.37 kg (95% CI −3.30 to −1.44).

Incorporating liquid meal replacements can aid in weight loss for individuals with type 2 diabetes.

The low-carbohydrate diet (LCD) arm lost an average of 12.3 kg compared to a loss of 0.60 kg in the control arm (P < 0.001).

Implementing a low-carbohydrate diet may significantly aid in weight loss for men with recurrent prostate cancer.

Mean percentage weight change at 1 year was -5.1% with semaglutide compared to -2.2% with liraglutide (P < .001).

Semaglutide may be more effective than liraglutide for weight loss in clinical practice.

Weight change at 6 months was -4.31% for the standardized group and -3.26% for the personalized group.

Both diet approaches resulted in weight loss, but the standardized low-fat diet was more effective.

Tirzepatide facilitated an average 18.5% weight loss (>46 pounds) in overweight and obese patients with type 1 diabetes at 1 year.

Practitioners may consider tirzepatide as an effective option for weight management in this patient population.

Body fat was reduced to very low levels (∼5%) immediately before competition, but this corresponded with a loss of lean mass.

Practitioners should be aware that extreme fat loss can lead to loss of lean mass.

Two years of calorie restriction (CR) resulted in a 7.7 kg decrease in body weight in the CR group.

Calorie restriction can lead to significant weight loss over two years.

Optimal carbohydrate and protein intakes are vital for modulating training adaptation, recovery, and exercise performance.

Athletes should prioritize adequate carbohydrate and protein intake to enhance training and performance.

Current recommendations should be used as a basis for an individualized approach to nutrition for female athletes.

Coaches and nutritionists should customize nutrition plans for female athletes based on individual needs and menstrual cycle effects.

Adequate dietary sources or supplements of specific nutrients are necessary for vegan diets.

Health professionals should ensure that vegan patients receive adequate nutrients through diet or supplements.

DIAAS scores and available protein were higher for omnivorous versus vegetarian athletes (+11% and +43%, respectively, p < 0.05).

Athletes following an omnivorous diet may have better protein quality compared to those on a vegetarian diet.

Omnivorous participants had significantly higher lean body mass than vegetarian participants (+14%).

Omnivorous athletes may have an advantage in lean body mass compared to vegetarian athletes.

Vegetarian athletes would need to consume, on average, an additional 10 g protein daily to reach the recommended intake for protein (1.2 g/kg/d).

Vegetarian athletes should consider increasing their protein intake to meet recommended levels.

The Mediterranean Diet may be of greater interest for the management of T2DM.

Consider recommending the Mediterranean Diet as a potential strategy for managing T2DM.

The recommended dietary prescription for the Mediterranean Diet includes 40-50% carbohydrates, 15-25% proteins, and 25-35% fats.

Use these macronutrient guidelines when advising patients on the Mediterranean Diet for T2DM management.

The ACSM supports the inclusion of physical activity in medical treatments for excess weight and adiposity.

Practitioners should incorporate physical activity into treatment plans for patients with excess weight.

For weight loss and prevention of weight gain, physical activity should be progressed to at least 150 min·wk-1 of moderate-intensity.

Encourage clients to engage in at least 150 minutes of moderate-intensity physical activity weekly for effective weight management.

The low-carbohydrate diet intervention group had a significant reduction in body weight of -5.9 kg.

A low-carbohydrate diet may contribute to significant weight loss in individuals with prediabetes or untreated diabetes.

Intensive, multicomponent behavioural interventions for overweight and obese adults can lead to weight loss.

Encourage intensive behavioral interventions for weight management in obese adults.

Supporting an athlete's need for autonomy by allowing choices concerning training variables can be an effective coaching strategy.

Coaches should incorporate autonomy in training to enhance effectiveness.